Foundation for Liver Research [clinicaltrials_resource:3db0c920be3993a8f11600ca68b72b14]
affiliation [clinicaltrials_vocabulary:affiliation]
Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection [clinicaltrials:NCT00352235]Influence of Ribavirin and Interferon on Semen Quality, IRIS Study [clinicaltrials:NCT00455832]clinicaltrials:NCT00662220clinicaltrials:NCT01373684clinicaltrials:NCT01430234Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms [clinicaltrials:NCT01641094]A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device [clinicaltrials:NCT02167074]Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer. [clinicaltrials:NCT02292745]
collaborator [clinicaltrials_vocabulary:collaborator]
48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection [clinicaltrials:NCT00114361]Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment [clinicaltrials:NCT00133276]Long Term Follow-up of Pegylated-Interferon Alpha-2b [clinicaltrials:NCT00146705]Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection [clinicaltrials:NCT00352235]KRN7000 in Chronic Hepatitis B [clinicaltrials:NCT00363155]Pegintron Induction Therapy in HCV Non-Responders [clinicaltrials:NCT00363259]High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV [clinicaltrials:NCT00381953]Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. [clinicaltrials:NCT00422838]Influence of Ribavirin and Interferon on Semen Quality, IRIS Study [clinicaltrials:NCT00455832]Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders [clinicaltrials:NCT00624325]clinicaltrials:NCT00662220clinicaltrials:NCT00736983Colesevelam Versus Placebo in Cholestatic Pruritus [clinicaltrials:NCT00756171]Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B [clinicaltrials:NCT00877760]PEG-IFN in HBV Patients With Incomplete Response to NA [clinicaltrials:NCT00883844]Entecavir for Chronic Hepatitis B [clinicaltrials:NCT01323452]clinicaltrials:NCT01373684clinicaltrials:NCT01401387Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study [clinicaltrials:NCT01401400]clinicaltrials:NCT01430234Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B [clinicaltrials:NCT01532843]Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms [clinicaltrials:NCT01641094]Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures [clinicaltrials:NCT01661686]clinicaltrials:NCT01958190A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device [clinicaltrials:NCT02167074]Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients [clinicaltrials:NCT02282709]Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer. [clinicaltrials:NCT02292745]
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
organization [clinicaltrials_vocabulary:organization]
48 Weeks Combination Therapy for Patients With HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection [clinicaltrials:NCT00114361]Prophylaxis of Psychiatric Symptoms During Anti-HCV Treatment [clinicaltrials:NCT00133276]Long Term Follow-up of Pegylated-Interferon Alpha-2b [clinicaltrials:NCT00146705]Phase I/II Trial of KRN7000 in Patients With Chronic Hepatitis C Infection [clinicaltrials:NCT00352235]KRN7000 in Chronic Hepatitis B [clinicaltrials:NCT00363155]Pegintron Induction Therapy in HCV Non-Responders [clinicaltrials:NCT00363259]High-dose IFN and PEG IFN for Induction Therapy in Difficult to Treat Genotype 1 Patients With Chronic HCV [clinicaltrials:NCT00381953]Study Investigating Immunological Effects of Treatment for Chronic Hepatitis C Patients. [clinicaltrials:NCT00422838]Influence of Ribavirin and Interferon on Semen Quality, IRIS Study [clinicaltrials:NCT00455832]Subcutaneous Continuous Infusion of Interferon Alfa-2b and Ribavirin in Hepatitis C Genotype 1 Nonresponders [clinicaltrials:NCT00624325]clinicaltrials:NCT00662220clinicaltrials:NCT00736983Colesevelam Versus Placebo in Cholestatic Pruritus [clinicaltrials:NCT00756171]Augmenting Response to Entecavir With Peginterferon a-2a for the Treatment of HBeAg-positive Chronic Hepatitis B [clinicaltrials:NCT00877760]PEG-IFN in HBV Patients With Incomplete Response to NA [clinicaltrials:NCT00883844]Entecavir for Chronic Hepatitis B [clinicaltrials:NCT01323452]clinicaltrials:NCT01373684clinicaltrials:NCT01401387Genetic Study of Peginterferon Treatment in Hepatitis B Patients: The GIANT-B Study [clinicaltrials:NCT01401400]clinicaltrials:NCT01430234Lowering Viral Load With Nucleos(T)Ide Analogues Prior to Peginterferon Alfa-2b Treatment to Increase Sustained Response in HBeAg-positive Chronic Hepatitis B [clinicaltrials:NCT01532843]Effect of Teleprevir in Triple Therapy on Intrahepatic Immunological Mechanisms [clinicaltrials:NCT01641094]Fully Covered or Partially Covered Stents in Malignant Esophageal Strictures [clinicaltrials:NCT01661686]clinicaltrials:NCT01958190A Multicenter Trial, Comparing a 25G EUS Fine Needle Aspiration (FNA) Device With a 20G EUS ProCore Fine Needle Biopsy (FNB) Device [clinicaltrials:NCT02167074]Effect of ASV and DCV Therapy on the Quality of Immune Status in Chronic HCV Patients [clinicaltrials:NCT02282709]Efficacy and Feasibility of Combining FOLFIRINOX and Stereotactic Radiotherapy for Patients With Irresectable Locally Advanced Pancreatic Cancer. [clinicaltrials:NCT02292745]
source [clinicaltrials_vocabulary:source]
Foundation for Liver Research [clinicaltrials_resource:3db0c920be3993a8f11600ca68b72b14]
Bio2RDF identifier
3db0c920be3993a8f11600ca68b72b14
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:3db0c920be3993a8f11600ca68b72b14
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:3db0c920be3993a8f11600ca68b72b14
title
Foundation for Liver Research
@en
type
label
Foundation for Liver Research [clinicaltrials_resource:3db0c920be3993a8f11600ca68b72b14]
@en